Results 241 to 250 of about 1,072,260 (332)

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Police Training Investigates the Fallibility of the Eye Witness

, 1960
James H. Chenoweth
openalex   +2 more sources

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Translation and psychometric evaluation of the Witness Perceived Safety Scale of prehospital emergency care. [PDF]

BMC Emerg Med
Vagrimogadam F, Karimollahi M, Mehri S.
europepmc   +1 more source

The Competency of Witnesses. Third Article

D. B. E.
openalex   +2 more sources

The Federal Witness Immunity Acts in Theory and Practice: Treading the Constitutional Tightrope

, 1963

openalex   +2 more sources

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Ethical Implications of Artificial Intelligence in Vaccine Equity: Protocol for Exploring Vaccine Distribution Planning and Scheduling in Pandemics in Low- and Middle-Income Countries.

JMIR Res Protoc
Akuma I, Vaswani V, Ekmekci EP.
europepmc   +1 more source

Justice at Risk? The Influence of Recidivism Risk Information on Evaluation of Evidence and Determination of Guilt. [PDF]

Behav Sci (Basel)
De Beuf TLF, van Es RMS, de Keijser JW, Otgaar H.   +3 more
europepmc   +1 more source

Federal Criminal Procedure: Subpoena of Nonresident Citizen as Witness before Grand Jury

, 1964
Andre A. Schwartz
openalex   +2 more sources